Organometallics
Article
̈
(16) (a) Wannberg, J.; Wallinder, C.; Unlsuoy, M.; Skold, C.; Larhed,
̈
̈
Mills, K. Heterocyclic Chemistry, 5th ed.; Wiley: Chichester, U.K., 2010.
(d) Sperry, J. D.; Wright, D. L. Curr. Opin. Drug Discovery 2005, 8,
723−740.
(2) Crescenzi, B.; Gardelli, C.; Muraglia, E.; Nizi, E.; Orvieto, F.;
Pace, P.; Pescatore, G.; Petrocchi, A.; Poma, M.; Rowley, M.; Scarpelli,
R.; Summa, V. (IRBM P. Angelitti S.P.A.). N-substituted hydroxypyr-
imidinone carboxamide inhibitors of HIV integrase. U.S. Patent
US7217713, July 24, 2006.
(3) Edmondson, S. D.; Fisher, M. H.; Kim, D.; MacCoss, M.;
Parmee, E. R.; Weber, A. E.; Xu, J. (Merck & Co., USA). Such as 7-
((3r)-3-amino-4-(3,4-di.fluorophenyl)butanoyl)-2-(trifluoromethyl)-
5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treat-
ment of insulin resistance disorders. U.S. Patent US6699871 B2, July
5, 2002.
(4) Roth, B. D. (Warner-Lambert Co., USA). Trans-6-[2-(3- or 4-
carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one in-
hibitors of cholesterol synthesis. U.S. Patent US4681893, May 30,
1986.
M. J. Org. Chem. 2013, 78, 4184−4189. (b) Grushin, V. V. Acc. Chem.
Res. 2010, 43, 160−171. (c) Yandulov, D. V.; Tran, N. T. J. Am. Chem.
Soc. 2007, 129, 1342−1358. (d) Grushin, V. V. Chem. - Eur. J. 2002, 8,
1006−1014.
(17) (a) Su, M.; Hoshiya, N.; Buchwald, S. L. Org. Lett. 2014, 16,
832−835. (b) Su, M.; Buchwald, S. L. Angew. Chem., Int. Ed. 2012, 51,
4710−4713. (c) Hooper, M. W.; Hartwig, J. F. Organometallics 2003,
22, 3394−3403. (d) Hooper, M. W.; Utsunomiya, M.; Hartwig, J. F. J.
Org. Chem. 2003, 68, 2861−2873.
(18) (a) Dufert, M. A.; Billinglsey, K. L.; Buchwald, S. L. J. Am. Chem.
̈
Soc. 2013, 135, 12877−12885. (b) Shen, Q.; Hartwig, J. F. J. Am.
Chem. Soc. 2007, 129, 7734−7735. (c) Shen, Q.; Shekhar, S.; Stambuli,
J. P.; Hartwig, J. F. Angew. Chem., Int. Ed. 2005, 44, 1371−1375.
(19) The corresponding oxidative addition complex of 3-
bromothiophene was also prepared, but it undergoes rapid
dearomatization in solution. See ref 15e as well as: Milner, P. J.;
Maimone, T. J.; Su, M.; Chen, J.; Muller, P.; Buchwald, S. L. J. Am.
̈
Chem. Soc. 2012, 134, 19922−19934. Thus, a solid-state structure of
for details.
(5) Kennis, L. E. J.; Vandenberk, J. (Janssen Pharmaceutica N.V.).
Psychological disorders. U.S. Patent US4804663A, March 27, 1985.
(6) (a) Gillis, E. P.; Eastman, K. J.; Hill, M. D.; Donnelly, D. J.;
chem.5b00258. (b) Purser, S.; Moore, P. R.; Swallow, S.; Gouverneur,
V. Chem. Soc. Rev. 2008, 37, 320−330. (c) Kirk, K. L. Org. Process Res.
(20) The solid-state structure of 13 consisted of two rotamers of the
thiophene ring; only the major rotamer is shown for convenience.
(21) For other examples, see: (a) Verswyvel, M.; Steverlynck, J.;
Mohamed, S. H.; Trabelsi, M.; Champagne, B.; Koeckelberghs, G.
Macromolecules 2014, 47, 4668−4675. (b) Verswyvel, M.; Verstappen,
P.; Cremer, L. D.; Verbiest, T.; Koeckelberghs, G. J. Polym. Sci., Part A:
Polym. Chem. 2011, 49, 5339−5349.
(22) Under all studied conditions, treatment of L3-ligated oxidative
addition complexes of five-membered heteroaryl bromides with AgF
led to incomplete conversion to what we tentatively assign as the
corresponding Pd−F complexes. Thus, it is likely that transmetalation
is also a challenging elementary step during this transformation.
(23) Roy, A. H.; Hartwig, J. F. J. Am. Chem. Soc. 2001, 123, 1232−
1233.
Dev. 2008, 12, 305−321. (d) Muller, K.; Faeh, C.; Diederich, F. Science
̈
2007, 317, 1881−1886.
(7) Gakh, A. A.; Kirk, K. L. Fluorinated Heterocycles. In Fluorinated
Heterocycles; Gakh, A. A., Kirk, K. L., Eds.; ACS Symposium Series
1003; American Chemical Society: Washington, DC, 2009; pp 3−20.
(8) (a) Fluorine in Heterocyclic Chemistry; Nenajdenko, V., Ed.;
Springer: New York, 2014; Vol. 1 (5-Membered Heterocycles and
Macrocycles). (b) Kirk, K. L. Fluorinated Five-Membered Nitrogen-
Containing Heterocycles. In Fluorinated Heterocyclic Compounds:
Synthesis, Chemistry, and Applications; Petrov, V. A., Ed.; Wiley:
Hoboken, NJ, 2009; pp 91−158. (c) Shermolovich, Y. Fluorinated
Five-Membered Heterocycles Containing Oxygen, Sulfur, Selenium,
and Phosphorus. In Fluorinated Heterocyclic Compounds: Synthesis,
Chemistry, and Applications; Petrov, V. A., Ed.; Wiley: Hoboken, NJ,
2009; pp 159−225.
(24) Gronowitz, S.; Hornfeldt, A.-B. Thiophenes; Elsevier: Am-
̈
sterdam, The Netherlands, 2004.
(25) Hartwig, J. F. Inorg. Chem. 2007, 46, 1936−1947.
(26) It should be noted that the addition of tBuOD to these reaction
mixtures did not result in deuterium incorporation into aryl fluoride
products (see ref 15b), as judged by 19F NMR and GC/MS analysis.
This finding suggests either that regioisomer formation in these cases
proceeds through a mechanism different from that outlined in ref 15b,
or that the involved Pd−thiophyne intermediate is too short-lived to
allow for adequate H/D exchange prior to reprotonation and reductive
elimination. Further study of this phenomenon is required.
(27) A number of other, non-benzo-fused bromofurans were also
evaluated, but most underwent significant decomposition under the
reaction conditions (see Table S1 in the Supporting Information).
Halogenated furans are known to exhibit poor stability (see ref 8a and
the references cited therein for details).
(9) (a) Balz, G.; Schiemann, G. Ber. Dtsch. Chem. Ges. B 1927, 60,
1186−1190. (b) Kirk, K. L.; Cohen, L. A. J. Am. Chem. Soc. 1973, 95,
4619−4624.
(10) (a) Sun, H.; DiMagno, S. G. Angew. Chem., Int. Ed. 2006, 45,
2720−2725. (b) Finger, G. C.; Kruse, C. W. J. Am. Chem. Soc. 1956,
78, 6034−6037.
(11) For (hetero)aryllithium reagents, see: (a) Nagaki, A.; Uesugi, Y.;
Kim, H.; Yoshida, J.-i. Chem. - Asian J. 2013, 8, 705−708. See also the
Grignard reagents, see:. (b) Yamada, S.; Gavryushin, A.; Knochel, P.
Angew. Chem., Int. Ed. 2010, 49, 2215−2218 and references cited
therein.
(12) Hutchinson, J.; Sandford, G. Top. Curr. Chem. 1997, 193, 1−43.
(13) Campbell, M.; Ritter, T. Chem. Rev. 2015, 115, 612−633.
(14) For rare examples, see: (a) Wang, D.; Sun, W.; Chu, T. Eur. J.
Org. Chem. 2015, 2015, 4114−4118. (b) Ichiishi, N.; Canty, A. J.;
Yates, B. F.; Sanford, M. S. Org. Lett. 2013, 15, 5134−5137.
(c) Truong, T.; Klimovica, K.; Daugulis, O. J. Am. Chem. Soc. 2013,
135, 9342−9345.
(28) Unfortunately, to date we have been unable to prepare five-
membered heteroaryl bromides bearing secondary or tertiary alkyl
groups in the ortho position. For example, attempts to carry out
selective Negishi couplings between 2,3-dibromothiophene and
secondary or tertiary alkylzinc nucleophiles led to complex mixtures
of products.
(15) (a) Sather, A. C.; Lee, H. G.; De La Rosa, V. Y.; Buchwald, S. L.
Submitted for publication. (b) Milner, P. J.; Kinzel, T.; Zhang, T.;
Buchwald, S. L. J. Am. Chem. Soc. 2014, 136, 15757−15766. (c) Lee,
H. G.; Milner, P. J.; Buchwald, S. L. J. Am. Chem. Soc. 2014, 136,
3792−3795. (d) Lee, H. G.; Milner, P. J.; Buchwald, S. L. Org. Lett.
2013, 15, 5602−5605. (e) Maimone, T. J.; Milner, P. J.; Kinzel, T.;
Zhang, Y.; Takase, M. K.; Buchwald, S. L. J. Am. Chem. Soc. 2011, 133,
18106−18109. (f) Noel, T.; Maimone, T. J.; Buchwald, S. L. Angew.
̈
Chem., Int. Ed. 2011, 50, 8900−8903. (g) Watson, D. A.; Su, M.;
Teverovskiy, G.; Zhang, Y.; García-Fortanet, J.; Kinzel, T.; Buchwald,
S. L. Science 2009, 325, 1661−1664.
F
Organometallics XXXX, XXX, XXX−XXX